CA2497410A1 - Antibacterial pyrazole carboxylic acid hydrazides - Google Patents

Antibacterial pyrazole carboxylic acid hydrazides Download PDF

Info

Publication number
CA2497410A1
CA2497410A1 CA002497410A CA2497410A CA2497410A1 CA 2497410 A1 CA2497410 A1 CA 2497410A1 CA 002497410 A CA002497410 A CA 002497410A CA 2497410 A CA2497410 A CA 2497410A CA 2497410 A1 CA2497410 A1 CA 2497410A1
Authority
CA
Canada
Prior art keywords
substituted
unsubstituted
group
alkyl
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002497410A
Other languages
English (en)
French (fr)
Inventor
Michelle M. Butler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbiotix Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2497410A1 publication Critical patent/CA2497410A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002497410A 2002-09-10 2003-09-10 Antibacterial pyrazole carboxylic acid hydrazides Abandoned CA2497410A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40943902P 2002-09-10 2002-09-10
US60/409,439 2002-09-10
PCT/US2003/028392 WO2004094370A2 (en) 2002-09-10 2003-09-10 Antibacterial pyrazole carboxylic acid hydrazides

Publications (1)

Publication Number Publication Date
CA2497410A1 true CA2497410A1 (en) 2004-11-04

Family

ID=33309471

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002497410A Abandoned CA2497410A1 (en) 2002-09-10 2003-09-10 Antibacterial pyrazole carboxylic acid hydrazides

Country Status (6)

Country Link
US (1) US20060258729A1 (cg-RX-API-DMAC7.html)
EP (1) EP1549143A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006508178A (cg-RX-API-DMAC7.html)
AU (1) AU2003303953B2 (cg-RX-API-DMAC7.html)
CA (1) CA2497410A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004094370A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006017505A2 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
US7786139B2 (en) 2006-11-21 2010-08-31 Omeros Corporation PDE10 inhibitors and related compositions and methods
WO2011031935A1 (en) * 2009-09-11 2011-03-17 Glsynthesis Inc. Selective antibacterials for clostridium difficile infections
WO2014059429A2 (en) * 2012-10-12 2014-04-17 Health Research, Inc. Small molecules inhibiting oncoprotein myc
US20240139191A1 (en) * 2020-12-14 2024-05-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Small molecules as larp1 ligands
UY39882A (es) * 2021-08-02 2023-06-15 Eurofarma Laboratorios S A COMPUESTOS NACILHIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232685B2 (en) * 2001-12-19 2007-06-19 The Regents Of The Universtiy Of California Cell lines with latent immunodeficiency virus and methods of use thereof
WO2003105840A2 (en) * 2002-06-17 2003-12-24 The Pennsylvania State Research Foundation Sphingosine kinase inhibitors

Also Published As

Publication number Publication date
AU2003303953B2 (en) 2007-10-04
EP1549143A2 (en) 2005-07-06
AU2003303953A1 (en) 2004-11-19
WO2004094370A3 (en) 2005-03-03
WO2004094370A2 (en) 2004-11-04
US20060258729A1 (en) 2006-11-16
JP2006508178A (ja) 2006-03-09

Similar Documents

Publication Publication Date Title
ES2331250T3 (es) Inhibidores de la girasa bacteriana y usos de los mismos.
US8877940B2 (en) Antibiotic tolerance inhibitors
RU2609259C2 (ru) Пиримидиновые ингибиторы гиразы и топоизомеразы iv
JP2007502861A (ja) 抗菌方法及び組成物
US9540389B2 (en) Antimicrobial potentiators
US20250115594A1 (en) Antibacterial agents: soluble salts and aqueous formulations of pyronins
KR20150089086A (ko) 박테리아 감염을 치료하기 위한 조성물 및 방법
US11731946B2 (en) Broad spectrum antivirulence, anti-persistence compounds
US12016874B2 (en) Methods and compositions for treating carbapenem-resistant klebsiella pneumoniae infections
WO2010136804A1 (en) Pyrimidine derivatives for use as antibiotics
AU2003303953B2 (en) Antibacterial pyrazole carboxylic acid hydrazides
KR101329587B1 (ko) 항균제로서의 퀴놀린 유도체
AU2015339039B2 (en) Synergistic compositions for treating microbial infections
US12502362B2 (en) Inhibitors of nucleotidyltransferase superfamily enzymes as antibiotics
JP7621502B2 (ja) ビフェニル誘導体化合物を有効成分として含有する抗菌補助剤及びこの用途
WO2013148269A1 (en) Methods and compositions for reducing the proliferation of gram positive bacteria
CN119630393A (zh) 抗微生物化合物
US12285407B2 (en) Bis-indolylmethane derivatives and uses thereof
CN117545485A (zh) 抗菌化合物
CN121622671B (zh) 美罗培南或氨曲南与萘啶酸联用在制备抗菌药物中的应用
TW200418508A (en) Peptide deformylase activated prodrugs
US20260041683A1 (en) Compounds with Anti-Acinetobacter Baumannii Activity
US8268825B2 (en) Method for the treatment of anthrax infections
MXPA02008368A (es) Ectatm antiinfeccioso.
NZ612912A (en) Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{ 1-hydroxy-1-methyl-ethyl} pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl} -1h-benzimidazol-2-yl]urea

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued